NCT04605198

Brief Summary

Posttraumatic stress disorder (PTSD) is a major public health concern that disproportionately effects minorities and those with low-socioeconomic status, such as homeless women, creating a critical health disparity. PTSD has been linked with dysregulated hypothalamic-pituitary-adrenal (HPA) functioning and increased inflammation, which can lead to long-term physical-health problems and PTSD-symptom maintenance, exacerbating disparities. Mindfulness-based interventions, including Mindfulness-based Stress Reduction (MBSR), have shown promise as a complementary tool for addressing PTSD in veterans and with low-income, minority populations, but homeless women have not been examined adequately. MBSR may improve PTSD symptomatology and help modulate the dysregulated stress response common in individuals with PTSD, improving physical and mental health concurrently. This project is an open-label, parallel, modified-cross over clinical trial of a modified-MBSR intervention to reduce PTSD symptoms in homeless women and to explore physiological correlates of treatment-response. Hypotheses:

  1. 1.Participation in an MBSR-based intervention will be associated with clinically significant reduction in PTSD (primary outcome), lower depression symptoms and greater drug and alcohol abstinence (secondary outcomes) compared to participation in an attention control.
  2. 2.Compared to an attention control, participants in an MBSR-based intervention group will demonstrate improvements in cortisol reactivity and lower inflammation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
156

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 6, 2020

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

October 21, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 27, 2020

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2023

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

February 20, 2025

Completed
Last Updated

March 11, 2025

Status Verified

February 1, 2025

Enrollment Period

2.7 years

First QC Date

October 21, 2020

Results QC Date

November 19, 2024

Last Update Submit

February 19, 2025

Conditions

Keywords

PTSDTrauma

Outcome Measures

Primary Outcomes (1)

  • Post-traumatic Stress Symptoms (PTSD) as Measured by the PTSD Checklist for DSM 5 (PCL-5) (DSM=Diagnostic and Statistical Manuel of Mental Disorders).

    Change in Posttraumatic Stress Symptoms Disorder symptoms (i.e., decrease in symptoms), as measured by the PTSD Checklist for DSM 5 (PCL-5) (DSM=Diagnostic and Statistical Manuel of Mental Disorders). The PCL-5 is a 20-item scale (range 0-80), with rating scale descriptions: 0 "Not at all," 1 "A little bit," 2 "Moderately," 3 "Quite a bit," and 4 "Extremely." Higher scores indicate more PTSD symptoms.

    Immediately post-intervention & 6-month follow-up

Secondary Outcomes (5)

  • Depression

    Immediately post-intervention & 6-month follow-up

  • Substance Use Measured by the Texas Christian University Screen for Diagnostic and Statistical Manuel of Mental Disorders, 5th Edition (TCU 5)

    Immediately post-intervention & 6-month follow-up

  • Number of Participants With Positive Substance Use Measured by a 5-panel FDA-approved Urine Test Cup

    Immediately post-intervention & 6-month follow-up

  • Cortisol Reactivity

    Immediately post-intervention & 6-month follow-up

  • C-Reactive Protein (CRP)

    Immediately post-intervention & 6-month follow-up

Study Arms (2)

Modified Mindfulness-based Stress Reduction

EXPERIMENTAL
Behavioral: Modified Mindfulness-based Stress Reduction

Health Promotion Attention Control

ACTIVE COMPARATOR
Behavioral: Health Promotion Wellness Classes

Interventions

Participants will be trained in mindfulness meditation and the applicability of mindfulness practices to daily life. During MBSR programming, teachers will lecture about key topics in mindfulness and lead class discussions. Participants are given homework assignments, such as listening to guided meditations. Participants are given opportunities to ask the instructor questions and to share their experiences with each other. Each session focuses on a different key topic. Topics are: Session 1: Introduction; Session 2: Understanding Perceptions; Session 3: Hatha Yoga, Sitting Meditation, Walking Meditation; Session 4: Concentration \& Awareness; Session 5: Unhealthy Patterns \&Getting Unstuck; Session 6: Transformational Coping Strategies; Session 7: Mini-retreat; Session 8: Maintaining Discipline \& Flexibility; Session 9: Course Review.

Also known as: modified MBSR
Modified Mindfulness-based Stress Reduction

Sessions will cover the following general wellness topics: Session 1; Introduction; Session 2: Envisioning Health Through Art; Session 3: Chronic Disease 1 (Heart Health); Session 4: Chronic Disease II (Diabetes); Session 5: Nutrition and Hydration; Session 6: Infectious Disease Prevention; Session 7: Skin Care; Session 8: Oral Health; Session 9: Promoting Social Integration \& Course Graduation.

Health Promotion Attention Control

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsOnly women are eligible for the study.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • self-reported homeless women
  • age 18+
  • willing to provide informed consent
  • lifetime exposure to at least one Diagnostic and Statistical Manuel of Mental Disorders, version 5 (DSM-5) qualifying trauma
  • likely subthreshold or threshold PTSD, as measured by the PTSD Checklist for Civilians for DSM-5.
  • Note: A homeless person is defined as anyone who spent the previous night in a public or private shelter, or on the street.

You may not qualify if:

  • not speaking English
  • judged to be cognitively impaired; as indicated by score \>9 on the Short-Blessed Screener (SBS).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

North County Serenity House

Escondido, California, 92026, United States

Location

Prototypes Women's Center

Pomona, California, 91767, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticDepressionSubstance-Related DisordersWounds and Injuries

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersBehavioral SymptomsBehaviorChemically-Induced Disorders

Limitations and Caveats

Participants were not assigned on a 1:1 ratio. Some courses lasted more than 8 weeks due to vacillating quarantines and lockdowns during COVID-19 outbreaks. Relatedly, participants who were discharged from the site were not allowed to participate in follow-up sessions due to COVID-19 quarantines in 2020-2021, contributing to increased attrition over time. Additional MBSR participants were enrolled to adjust for this, allowing for adequate power but resulting in an unbalanced design.

Results Point of Contact

Title
Dr. Dana Rose Garfin, Associate Professor
Organization
University of California, Los Angeles

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be recruited from two sites. To avoid contamination between subjects living at the sites, using a quasi-randomized method, all participants at each site will receive the same treatment per cohort. Sites will alternate between the assignment of treatment (modified-MBSR) or control (health promotion class) in sequential cohorts to account for between site differences.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Adjunct Professor

Study Record Dates

First Submitted

October 21, 2020

First Posted

October 27, 2020

Study Start

October 6, 2020

Primary Completion

June 22, 2023

Study Completion

June 22, 2023

Last Updated

March 11, 2025

Results First Posted

February 20, 2025

Record last verified: 2025-02

Locations